Malaysian consumer group wants inquiry into COVID-19 vaccine management

The Malaysian Consumers Association (PPIM) is calling on the government to form a Royal Commission of Inquiry (RCI) to thoroughly investigate the management of COVID-19 vaccines. The consumer group argues that such an inquiry is essential for consolidating all available information and public complaints related to the vaccine program.

Datuk Nadzim Johan, Chief Activist for PPIM, emphasized the importance of an RCI in obtaining a complete picture of the vaccine rollout. He stated that the commission would serve as a central platform for collecting diverse perspectives and addressing public concerns. This move reflects ongoing public scrutiny and a demand for transparency regarding the vaccination process.

PPIM asserts that the Malaysian public is still seeking clarity on numerous issues surrounding the COVID-19 vaccines. The call for an RCI suggests a desire for a formal, high-level investigation to uncover facts and potentially identify areas for improvement in public health policy and execution. The association believes this comprehensive approach is necessary to build public trust and provide definitive answers.